tiprankstipranks
Trending News
More News >
Petros Pharmaceuticals Inc (PTPI)
:PTPI
US Market

Petros Pharmaceuticals (PTPI) Income Statement

Compare
201 Followers

Petros Pharmaceuticals Income Statement

Last quarter (Q1 2025), Petros Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Petros Pharmaceuticals's net income was $-2.26M. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.11M$ 5.82M$ 5.99M$ 7.81M$ 9.56M
Gross Profit
$ 3.90M$ 4.19M$ 3.70M$ 6.21M$ 5.51M
Operating Expenses
$ 21.58M$ 17.81M$ 19.55M$ 24.26M$ 22.80M
Depreciation and Amortization
$ 2.94M$ 3.42M$ 5.72M$ 6.98M$ 6.75M
EBITDA
$ -10.81M$ -4.21M$ -13.73M$ -1.64M$ -12.21M
Operating Income
$ -17.68M$ -13.62M$ -15.85M$ -18.05M$ -17.28M
Other Income/Expenses
$ 3.36M$ 5.45M$ -121.82K$ 9.06M$ -4.73M
Pretax Income
$ -14.32M$ -8.16M$ -20.04M$ -8.99M$ -22.01M
Net Income
$ -14.32M$ -8.16M$ -20.04M$ -9.36M$ -20.59M
Per Share Metrics
Basic EPS
$ -0.02$ -6.35$ -9.68$ -8.25$ -38.55
Diluted EPS
$ -0.02$ -6.35$ -9.68$ -8.25$ -38.55
Weighted Average Shares Outstanding
8.03M 1.29M 2.07M 1.09M 534.07K
Weighted Average Shares Outstanding (Diluted)
8.03M 2.18M 2.07M 1.09M 534.07K
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis